2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06
±³À°ÀÏÀÚ : 2024-07-06
±³À°Àå¼Ò : SCÄÁº¥¼Ç¼¾ÅÍ, ¾Æ³ªÀ̽ºÈ¦
±³À°ÁÖÁ¦ : 2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå-Á¾¾çÇÐ ¿¬±¸È¸
´ã´çÀÚ : Â÷¿¬Á¤
¿¬¶ôó : 02-6002-1394
À̸ÞÀÏ : cardiooncology@naver.com
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í Àü¹®ÀÇ »çÀüµî·Ï-1¸¸¿ø, ÇöÀåµî·Ï-2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 09:00~09:20 Cardiac biomarkers for initial screening of CTRCD: ÇÙ½É °á°ú °ª Çؼ®°ú À¯ÀÇÁ¡ ȲÈñÁ¤(°æÈñÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 09:20~09:40 Echocardiography for detection of CTRCD: ÇÙ½É °á°ú °ª Çؼ®°ú À¯ÀÇÁ¡ ÃÖ°¿î(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 09:40~10:00 Medical treatment of CTRCD: How and how long? ¹ÚÇõÁø(Àü³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 10:00~10:20 SGLT2 inhibitors: The emergence of a new rookie in the field of cardio-oncology Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)
Åä·Ð 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 10:20~10:40 Discussion ±è´Ù·¡,±èÁöÇü,±èÀÎö,À̼ºÀ±,ÀÓ°æÈñ,±è±Ô,¹ÚÀαÙ,¹Ú¼¼ÈÆ,±è¹Î°æ,À±ÇöÁÖ(¼º±Õ°üÀÇ´ë,¿¬¼¼ÀÇ´ë,°è¸íÀÇ´ë,ÀÎÁ¦ÀÇ´ë,µ¿¾ÆÀÇ´ë,¿¬¼¼ÀÇ´ë,¿ï»êÀÇ´ë,¼º±Õ°üÀÇ´ë,¿µ³²ÀÇ´ë,Àü³²ÀÇ´ë)
ÈÞ½Ä 07¿ù 06ÀÏ 10:40~11:00 Coffee Break ()
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 11:00~11:20 [Keynote Lecture] Immune checkpoint inhibitor: Current uses and future directions ÀÌÀ±±Ô(°ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 11:20~11:40 [Interactive consultation 1] ICI myocarditis and non-inflammatory LV dysfunction ±è¹Ì³ª(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 11:40~12:00 [Interactive consultation 2] ACS and atherosclerosis during chemotherapy ¿À±Ôö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 12:00~12:20 [ÇÙ½ÉÁ¤¸®] Interpretation of ECG in patients using ICI (Çʼö ½ÉÀüµµÇؼ® ¹× Up-to-date ¸ð´ÏÅ͸µ ¹æ¹ý ¼Ò°³) ±è´ëÈÆ(¿¬¼¼ÀÇ´ë)
Åä·Ð 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 12:20~12:30 Discussion ÀÌÁöÀº,ÃÖÇýÁø,¼ÕÀå¿ø,±èµµ¿µ,½É¼ºÈÆ,°û¹ÌÇâ,ÀÌ´©¸®,ÇöÁØÈ£,Á¤ÁöÀ±(°¡Å縯ÀÇ´ë,¿¬¼¼ÀÇ´ë,¿µ³²ÀÇ´ë,¾ÆÁÖÀÇ´ë,±¹¸³¾Ï¼¾ÅÍ,±¹¸³¾Ï¼¾ÅÍ,Àü³²ÀÇ´ë,¿ï»êÀÇ´ë,¿µ³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 12:30~13:00 My journey to solve clinical unmet needs in cardiooncology À±È£Áß(°¡Å縯ÀÇ´ë)
½Ä»ç 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 13:00~14:00 Á¡½É½Ä»ç ¹× ÃÑȸ ()
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 14:00~14:20 °Ç°º¸Çè ºòµ¥ÀÌÅÍ ¿¬±¸ ¹× Çؼ® ½Ã À¯ÀÇÁ¡ ¾çÇʼº(Â÷ÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 14:20~14:40 Korean Cardio-oncology Fact Sheet: ºòµ¥ÀÌÅÍ À§¿øȸ È°µ¿°ú ÁÖ¿ä °á°ú ¹ßÇ¥ Á¶Àͼº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 14:40~15:00 °øÅë µ¥ÀÌÅÍ ¸ðµ¨°ú ºÐ»ê¿¬±¸¸Á, µ¥ÀÌÅÍ °áÇÕ¿¬±¸: Cardio-oncology- °Ç°º¸Çè ºòµ¥ÀÌÅÍ ¿¬±¸¸¦ ³Ñ¾î¼ À¯½ÂÂù(¿¬¼¼ÀÇ´ë)
Åä·Ð 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 15:00~15:10 Discussion À̼±È,Á¶ÀºÁ¤,À̼ºÀº,ÃÖÀÚ¿¬,À±Á¾Âù(°è¸íÀÇ´ë,Áß¾ÓÀÇ´ë,°¡Å縯ÀÇ´ë,°í·ÁÀÇ´ë,°¡Å縯ÀÇ´ë)